FORXIGA™ (dapagliflozin) now approved in European Union for treatment of type 2 diabetes
14 November 2012 | By AstraZeneca
The European Commission has approved FORXIGA™ (dapagliflozin) tablets...
List view / Grid view
14 November 2012 | By AstraZeneca
The European Commission has approved FORXIGA™ (dapagliflozin) tablets...
28 August 2012 | By Roche
Daniel O’Day appointed new Head of Roche Pharma– Roland Diggelmann will assume the position Head of Roche Diagnostics...
20 July 2011 | By Merck
Merck has signed a new non-exclusive agreement with Roche...
17 May 2011 | By Merck
Merck announced that it has entered into agreements with Roche...